Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Performance of progressive and adaptive COVID-19 exit strategies: a stress test analysis for managing intensive care unit rates

Jan-Diederik van Wees, Martijn van der Kuip, Sander Osinga, David van Westerloo, Michael Tanck, Maurice Hanegraaf, Maarten Pluymaekers, Olwijn Leeuwenburgh, Lonneke van Bijsterveldt, Pien Verreijdt, Logan Brunner, Marceline Tutu van Furth
doi: https://doi.org/10.1101/2020.05.16.20102947
Jan-Diederik van Wees
1TNO, Netherlands Organization for Applied Scientific Research, The Hague, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martijn van der Kuip
2Department of Pediatric Infectious Diseases and Immunology, Amsterdam Infection & Immunity Institute, Amsterdam University Medical Centers, Emma Children’s Hospital, Amsterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: m.vanderkuip@amsterdamumc.nl
Sander Osinga
1TNO, Netherlands Organization for Applied Scientific Research, The Hague, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David van Westerloo
3Department of Intensive Care Medicine, Leiden University Medical Center, Leiden, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Tanck
4Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam Public Health, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maurice Hanegraaf
1TNO, Netherlands Organization for Applied Scientific Research, The Hague, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maarten Pluymaekers
1TNO, Netherlands Organization for Applied Scientific Research, The Hague, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olwijn Leeuwenburgh
1TNO, Netherlands Organization for Applied Scientific Research, The Hague, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lonneke van Bijsterveldt
1TNO, Netherlands Organization for Applied Scientific Research, The Hague, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pien Verreijdt
5Faculty of Medicine, VUmc School of Medical Sciences, VU Amsterdam, Amsterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Logan Brunner
1TNO, Netherlands Organization for Applied Scientific Research, The Hague, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marceline Tutu van Furth
2Department of Pediatric Infectious Diseases and Immunology, Amsterdam Infection & Immunity Institute, Amsterdam University Medical Centers, Emma Children’s Hospital, Amsterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background In May 2020, many European countries have begun to introduce an exit strategy for the coronavirus disease 2019 (COVID-19) pandemic which involves relaxing social distancing measures. Predictive epidemiological modeling indicates that chances for resurgence are high. However, parametrization of the epidemiological nature of COVID-19 and the effect of relaxing social distancing is not well constrained, resulting in highly uncertain outcomes in view of managing future intensive care unit (ICU) needs.

Methods and findings For performance analysis of exit strategies we developed an open-source ensemble-based Susceptible-Exposed-Infectious-Removed (SEIR) model. It takes into account uncertainties for the COVID-19 parametrization and social distancing measures. The model is calibrated to data of the outbreak and lockdown phase. For the exit phase, the model includes the capability to activate an emergency brake, reinstating lockdown conditions. Alternatively, the model uses an adaptive COVID-19 cruise control (ACCC) capable to retain a targeted ICU level. The model is demonstrated for the Netherlands and we analyzed progressive and adaptive exit strategies through a stress test of managing ICU rates. The progressive strategy reflects the outcome of social and economic pressure to use one-way steering toward progressively relaxing measures at an early stage. It is marked by a high probability for the activation of the emergency brake due to an unsolicited growth of ICU needs in the following months. Alternatively, the two-way steering ACCC can flatten ICU needs in a more gradual way and avoids activation of the emergency brake. It also performs well for seasonal variation in the reproduction number of severe acute respiratory syndrome-coronavirus.

Conclusions The adaptive strategy (ACCC) is favored, as it avoids the use of the emergency brake at the expense of small steps of restrictive measures and allows the exploration of riskier and potentially rewarding measures in the future pathways of the exit strategy.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

none

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

We collected the data from publicly available data sources (ref 2, 14, 16 in main text). The modeling code and data used for our analysis is available under (ref 19: github.com/TNO/Covid-SEIR).

https://www.worldometers.info/coronavirus/

https://www.stichting-nice.nl

https://www.rivm.nl/documenten/epidemiologische-situatie-covid-19-in-nederland-6-mei-2020

https://github.com/TNO/Covid-SEIR

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted May 20, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Performance of progressive and adaptive COVID-19 exit strategies: a stress test analysis for managing intensive care unit rates
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Performance of progressive and adaptive COVID-19 exit strategies: a stress test analysis for managing intensive care unit rates
Jan-Diederik van Wees, Martijn van der Kuip, Sander Osinga, David van Westerloo, Michael Tanck, Maurice Hanegraaf, Maarten Pluymaekers, Olwijn Leeuwenburgh, Lonneke van Bijsterveldt, Pien Verreijdt, Logan Brunner, Marceline Tutu van Furth
medRxiv 2020.05.16.20102947; doi: https://doi.org/10.1101/2020.05.16.20102947
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Performance of progressive and adaptive COVID-19 exit strategies: a stress test analysis for managing intensive care unit rates
Jan-Diederik van Wees, Martijn van der Kuip, Sander Osinga, David van Westerloo, Michael Tanck, Maurice Hanegraaf, Maarten Pluymaekers, Olwijn Leeuwenburgh, Lonneke van Bijsterveldt, Pien Verreijdt, Logan Brunner, Marceline Tutu van Furth
medRxiv 2020.05.16.20102947; doi: https://doi.org/10.1101/2020.05.16.20102947

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (227)
  • Allergy and Immunology (503)
  • Anesthesia (110)
  • Cardiovascular Medicine (1238)
  • Dentistry and Oral Medicine (206)
  • Dermatology (147)
  • Emergency Medicine (282)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (531)
  • Epidemiology (10020)
  • Forensic Medicine (5)
  • Gastroenterology (499)
  • Genetic and Genomic Medicine (2452)
  • Geriatric Medicine (236)
  • Health Economics (479)
  • Health Informatics (1641)
  • Health Policy (752)
  • Health Systems and Quality Improvement (636)
  • Hematology (248)
  • HIV/AIDS (532)
  • Infectious Diseases (except HIV/AIDS) (11864)
  • Intensive Care and Critical Care Medicine (626)
  • Medical Education (252)
  • Medical Ethics (74)
  • Nephrology (268)
  • Neurology (2280)
  • Nursing (139)
  • Nutrition (352)
  • Obstetrics and Gynecology (454)
  • Occupational and Environmental Health (535)
  • Oncology (1245)
  • Ophthalmology (377)
  • Orthopedics (134)
  • Otolaryngology (226)
  • Pain Medicine (157)
  • Palliative Medicine (50)
  • Pathology (324)
  • Pediatrics (730)
  • Pharmacology and Therapeutics (311)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2280)
  • Public and Global Health (4831)
  • Radiology and Imaging (837)
  • Rehabilitation Medicine and Physical Therapy (491)
  • Respiratory Medicine (651)
  • Rheumatology (285)
  • Sexual and Reproductive Health (237)
  • Sports Medicine (227)
  • Surgery (267)
  • Toxicology (44)
  • Transplantation (125)
  • Urology (99)